Drug–Drug and Drug–Nutrients Interactions: From Theory to Clinical Relevance

Eline M. de Koning, Jeannine Huisbrink, Wilma Knol*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Abstract

Several changes in pharmacokinetics (PK) and pharmacodynamics (PD) are associated with ageing, complicating therapeutic management in older patients. Furthermore, older patients often suffer from multiple chronic diseases generating prescription of a growing number of drugs. Age-related changes in PK/PD, polypharmacy and multimorbidity play an important role in the prevalence of drug–drug interactions (DDIs) and drug–nutrient interactions (DNIs) in older people, which increases the risk of reduced drug efficacy and adverse drug events. This chapter first describes different mechanisms of DDIs and DNIs on a pharmacokinetic and pharmacodynamic level. Second, age-related changes in PK/PD are discussed, where changes in distribution, renal elimination and susceptibility to certain drug classes are of highest importance. Finally, this chapter provides an overview of commonly clinically relevant DDIs and DNIs in older people. Most clinically relevant DDIs are of pharmacodynamic origin and often include cardiovascular, antithrombotic and centrally acting drugs. The most common DNI is a pharmacokinetic interaction, where a nutrient or enteral feed affects the absorption of a drug.

Original languageEnglish
Title of host publicationOptimizing Pharmacotherapy in Older Patients
EditorsA. Cherubini, A.A. Mangoni, D. O’Mahony, M. Petrovic
PublisherSpringer Nature
Pages33-46
Number of pages14
ISBN (Electronic)978-3-031-28061-0
ISBN (Print)978-3-031-28060-3
DOIs
Publication statusPublished - 2023

Publication series

NamePractical Issues in Geriatrics
VolumePart F12
ISSN (Print)2509-6060
ISSN (Electronic)2509-6079

Keywords

  • Ageing
  • Drug–drug interactions
  • Drug–nutrition interactions
  • Pharmacodynamics
  • Pharmacokinetics

Fingerprint

Dive into the research topics of 'Drug–Drug and Drug–Nutrients Interactions: From Theory to Clinical Relevance'. Together they form a unique fingerprint.

Cite this